341 related articles for article (PubMed ID: 20463402)
1. Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia.
Coskun PE; Wyrembak J; Derbereva O; Melkonian G; Doran E; Lott IT; Head E; Cotman CW; Wallace DC
J Alzheimers Dis; 2010; 20 Suppl 2(0 2):S293-310. PubMed ID: 20463402
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.
Coskun PE; Beal MF; Wallace DC
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10726-31. PubMed ID: 15247418
[TBL] [Abstract][Full Text] [Related]
3. A mitochondrial etiology of Alzheimer and Parkinson disease.
Coskun P; Wyrembak J; Schriner SE; Chen HW; Marciniack C; Laferla F; Wallace DC
Biochim Biophys Acta; 2012 May; 1820(5):553-64. PubMed ID: 21871538
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.
Coskun P; Helguera P; Nemati Z; Bohannan RC; Thomas J; Samuel SE; Argueta J; Doran E; Wallace DC; Lott IT; Busciglio J
J Alzheimers Dis; 2017; 55(2):737-748. PubMed ID: 27802222
[TBL] [Abstract][Full Text] [Related]
5. Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease.
Helman AM; Siever M; McCarty KL; Lott IT; Doran E; Abner EL; Schmitt FA; Head E
J Alzheimers Dis; 2019; 67(1):103-112. PubMed ID: 30452414
[TBL] [Abstract][Full Text] [Related]
6. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome.
Busciglio J; Pelsman A; Wong C; Pigino G; Yuan M; Mori H; Yankner BA
Neuron; 2002 Feb; 33(5):677-88. PubMed ID: 11879646
[TBL] [Abstract][Full Text] [Related]
7. Genetic basis of Alzheimer's dementia: role of mtDNA mutations.
Grazina M; Pratas J; Silva F; Oliveira S; Santana I; Oliveira C
Genes Brain Behav; 2006; 5 Suppl 2():92-107. PubMed ID: 16681804
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer's disease hippocampi.
Rice AC; Keeney PM; Algarzae NK; Ladd AC; Thomas RR; Bennett JP
J Alzheimers Dis; 2014; 40(2):319-30. PubMed ID: 24448779
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase.
Mengel D; Liu W; Glynn RJ; Selkoe DJ; Strydom A; Lai F; Rosas HD; Torres A; Patsiogiannis V; Skotko B; Walsh DM
Alzheimers Res Ther; 2020 Mar; 12(1):27. PubMed ID: 32192521
[TBL] [Abstract][Full Text] [Related]
10. Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's disease.
Martin SB; Dowling AL; Lianekhammy J; Lott IT; Doran E; Murphy MP; Beckett TL; Schmitt FA; Head E
J Alzheimers Dis; 2014; 42(3):767-75. PubMed ID: 24927707
[TBL] [Abstract][Full Text] [Related]
11. Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease.
Wilcock DM; Hurban J; Helman AM; Sudduth TL; McCarty KL; Beckett TL; Ferrell JC; Murphy MP; Abner EL; Schmitt FA; Head E
Neurobiol Aging; 2015 Sep; 36(9):2468-74. PubMed ID: 26103884
[TBL] [Abstract][Full Text] [Related]
12. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
[TBL] [Abstract][Full Text] [Related]
13. Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome.
Naudé PJ; Dekker AD; Coppus AM; Vermeiren Y; Eisel UL; van Duijn CM; Van Dam D; De Deyn PP
J Alzheimers Dis; 2015; 45(3):733-43. PubMed ID: 25613101
[TBL] [Abstract][Full Text] [Related]
14. Lower mitochondrial DNA content but not increased mutagenesis associates with decreased base excision repair activity in brains of AD subjects.
Soltys DT; Pereira CPM; Rowies FT; Farfel JM; Grinberg LT; Suemoto CK; Leite REP; Rodriguez RD; Ericson NG; Bielas JH; Souza-Pinto NC
Neurobiol Aging; 2019 Jan; 73():161-170. PubMed ID: 30359878
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer's disease brain.
Klein HU; Trumpff C; Yang HS; Lee AJ; Picard M; Bennett DA; De Jager PL
Mol Neurodegener; 2021 Nov; 16(1):75. PubMed ID: 34742335
[TBL] [Abstract][Full Text] [Related]
16. Atypical aging in Down syndrome.
Zigman WB
Dev Disabil Res Rev; 2013; 18(1):51-67. PubMed ID: 23949829
[TBL] [Abstract][Full Text] [Related]
17. Plasma amyloid beta levels and platelet mitochondrial respiration in patients with Alzheimer's disease.
Fišar Z; Jirák R; Zvěřová M; Setnička V; Habartová L; Hroudová J; Vaníčková Z; Raboch J
Clin Biochem; 2019 Oct; 72():71-80. PubMed ID: 30954436
[TBL] [Abstract][Full Text] [Related]
18. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
Mehta PD; Capone G; Jewell A; Freedland RL
J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models.
Kumar S; Lemere CA; Walter J
Acta Neuropathol Commun; 2020 Jul; 8(1):118. PubMed ID: 32727580
[TBL] [Abstract][Full Text] [Related]
20. Composite Scores of Plasma Tau and β-Amyloids Correlate with Dementia in Down Syndrome.
Fang WQ; Hwu WL; Chien YH; Yang SY; Chieh JJ; Chang LM; Huang AC; Lee NC; Chiu MJ
ACS Chem Neurosci; 2020 Jan; 11(2):191-196. PubMed ID: 31799825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
